China’s First COVID-19 Vaccine Patent Granted To CanSino Biologics
Posted by
www.biotecnika.org
China's First COVID-19 Vaccine Patent Granted To CanSino Biologics
According to the Chinese Intellectual Property Administration, China's
vaccine maker CanSino Biologics Inc won the patent approval for its
COVID-19 vaccine candidate Ad5-nCoV, on Monday. According to
state-owned newspaper People's Daily, it is the first COVID-19 vaccine
patent granted by China. As per the patent document, […]
The post China's First COVID-19 Vaccine Patent Granted To CanSino
Biologics appeared first on BioTecNika .
https://www.biotecnika.org/2020/08/chinas-first-covid-19-vaccine-patent-granted-to-cansino-biologics/
Biotech News
Subscribe to:
Post Comments (Atom)
February 11, 2022 at 12:56 AM
Thanks for publishing such great information. You are doing such a great job. This information is very helpful for everyone. Keep sharing about Patent Lawyer Melbourne. Thanks.
Post a Comment